EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH

Purpose of the company: Pharmacological testing of new therapeutics and diagnostics in preclinical models.

Share capital: 30.200 EUR

Adress: Robert-Rössle-Str. 10 Haus 82 13125 Berlin Deutschland

Local court: 14057 Berlin (Charlottenburg)

Register number: HRB61814B

Free
Credit Report

Total assets

The average total assets of company EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH over the last 12 years is 4.066.848,20 €.

The company EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH as of the reporting date 2022 a bank balance of approx. 3.264.274,51 €. That is 95,13 % more than the average bank balance in the industry of companies with this total assets.

Equity ratio

The equity ratio of EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH is 83,30 % in the year 2022. In total, that ist 4.718.836,34 €.

Number of employees

The average number of employees of the company EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH for the years 2016 - 2022 is 42.

Annual profit

Change in liquidity compared to previous year

The average absolute change in liquidity of the company EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH compared to the previous year amounts to 12.548,59 €. That means that the liquidity of the company has increased or decreased by this amount per year on average.

The cash flow of the company EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH amounts to 138.034,52 € in the year 2022.

Publication dates of the annual financial statements

2006: 09.04.2008
2007: 15.01.2009
2008: 19.01.2010
2009: 22.12.2010
2010: 25.11.2011
2011: 21.01.2013
2012: 15.01.2014
2013: 25.09.2014
2014: 28.09.2015
2015: 12.10.2016
2016: 18.01.2018
2017: 21.01.2019
2018: 06.03.2020
2019: 03.02.2021
2020: 09.03.2022
2021: 29.03.2023
2022: 02.04.2024
2023: 03.04.2025

The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.

Source and reliability of the data

The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).

All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.

Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.